Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Lactoferrin on Pain Management Following Cesarean Section
NCT07502235Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Mar 2026
- Primary completion
- Aug 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Lactoferrin with Placebo (2 arms). Primary endpoint: Pain intensity at 24 hours. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
lactoferrin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07502235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07502235.